Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Qutenza in Post-surgical Neuropathic Pain
2021-001409-64Phase 3Active
- Sponsor
- Averitas Pharma, Inc.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of capsaicin in Neuralgia (2 arms), sponsored by Averitas Pharma, Inc. Started Jul 2021; status: active.
02
Drugs
capsaicin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2021-001409-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001409-64.